BioCryst’s promise

Charlie Gayer, Chief Commercial Officer for BioCryst, took to the stage, as he had done in Copenhagen for the 2024 HAEi Global Leadership Workshop. But Charlie wasn’t alone. His colleague Jinky Ang Rosselli, Chief Data Insights Officer, was also there, and for her, a conference in the Philippines was something of a homecoming.

Jinky told the audience that she was born in part of Manila and moved with her family to the US at a young age. She recounted the importance of family and gratitude in Filippino culture, and how working at BioCryst and hearing every day from the HAE community feels like an incredible gift.

Jinky said that there are several healthcare professionals in her family, so she understands the need to serve a community. She and her team do this in HAE by listening and learning from people with the disease to ensure the story is as complete as possible.

“We try to humanize the data and understand the communities we love.”

Jinky said that part of listening is understanding what the HAE community wants. And what BioCryst has learned is that the community wants therapies that work, especially as HAE is so unpredictable. Charlie and Jinky accepted that, in this part of the world, access to therapy is limited, and they are working hard on that.

Charlie then promised the audience: “We are going to make our drug accessible regardless of patients and the healthcare system’s ability to pay because we think it’s really important to have access. We don’t know how long that will take, and we thank you for everything you’ve done for us.”

BioCryst is a Diamond supporter of the 2025 HAEi Regional Conference APAC.